{"id":"W4376133764","doi":"10.3324/haematol.2022.282411","title":"Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; F. Hoffmann-La Roche","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Oncology; Internal medicine; Clinical trial; Stage (stratigraphy); Phases of clinical research; Pharmacology; Bone marrow; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002681596,0.0001595148,0.0007733778,0.0002344785,0.00003596084,0.000004960744,0.00004721216,0.00009159371,0.0002842419],"category_scores_gemma":[0.0001996902,0.00009827591,0.00004576286,0.0004954966,0.0001023131,0.00004475573,0.00002810049,0.00008897726,0.000004423417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003490144,"about_ca_system_score_gemma":0.0001030156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001372998,"about_ca_topic_score_gemma":0.0001130481,"domain_scores_codex":[0.9986736,0.0001101179,0.0005398357,0.0002645094,0.0002087262,0.000203248],"domain_scores_gemma":[0.9991092,0.0004156563,0.0001922522,0.0001694706,0.00004978419,0.000063607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6966456,0.03131032,0.1925836,0.0009738189,0.0004687144,0.002127778,0.008946468,0.00005628638,0.003352339,0.02990498,0.0001982466,0.03343181],"study_design_scores_gemma":[0.5875597,0.04954585,0.3162032,0.001268809,0.0001015463,0.00009441722,0.001365433,0.0004789454,0.04151672,0.0003746098,0.001200626,0.0002900811],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996591,0.0001374778,0.000009853968,0.0009229773,0.0000213158,0.001790882,0.00003494356,0.00002842844,0.0004631431],"genre_scores_gemma":[0.9982904,0.000760549,0.0003264439,0.00006777506,0.000006707782,0.0001842677,0.0000521681,0.00001221113,0.0002995066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1236196,"threshold_uncertainty_score":0.4007575,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03954079516253714,"score_gpt":0.3407638817034743,"score_spread":0.3012230865409371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}